SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Midterm election results and the prospect of a Democratic sweep dominate discussion, with traders blaming perceived regulatory and AI-spending risks for QQQs sharp volatility while others argue the outcome was priced in and the selloff is an overreaction. Strong AMD and Super Micro results also fueled optimism about AI-related tech and a possible rebound.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

U.S. midterm results and forecasts of Democratic gains are driving attention, with traders debating whether a shift in congressional control could weaken Trump politically and pressure his media-linked stock. Many posts are bearish on that prospect, while others argue midterm losses are typical or that a mixed result could limit the downside.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs quarterly earnings beat and stronger outlook, driven by surging AI data-center demand, sparked a sharp rally and renewed optimism about growth into 2027. Traders remain divided, with concerns about valuation, weaker cash flow and dependence on data-center spending weighing against the bullish outlook, while broader market and election worries contributed to volatile trading.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros quarterly results and raised full-year outlook, driven by strong AI-server demand, are the main focus. Many traders call the results a major beat and see the shares as undervalued, while others question thin margins, cash flow, and lingering management credibility concerns that may be weighing on the stocks muted response.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL chatter centers on sharp swings in semiconductor stocks amid concerns about an AI trade pullback, election uncertainty, and selling in chip names such as AMD, Intel, and Marvell. Traders remain divided between expecting a rebound on strong chip demand and earnings, and warning that persistent selling and leveraged-ETF decay could deepen losses.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Midterm-election uncertainty is driving volatility in Nvidia and the broader AI trade, with traders debating whether a Democratic sweep could weigh on data-center spending and AI regulation or whether the risk is already priced in. AMDs strong results are also fueling optimism that AI-chip demand remains resilient, supporting a semiconductor rebound.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on 28 HOPE-3 investigators letter urging FDA approval of deramiocel for non-ambulatory Duchenne muscular dystrophy, bolstering optimism ahead of the November 22 decision. Many traders see the letter as support for approval and anticipate short covering, while others point to the FDAs prior concerns and advisory-committee skepticism; claims of a leak remain speculation.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Election-related concerns about Musks political ties and possible scrutiny of Tesla and SpaceX dominate the discussion, alongside speculation about a potential merger between the companies. The mood is largely bearish, though some traders view a merger as a catalyst for upside, and short-term direction remains contested.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digitals sharp rebound after a steep selloff is drawing attention, with traders weighing analyst calls that the shares are undervalued and a broader AI-infrastructure recovery against the recent revenue miss and concerns about execution and financing. Some attribute the move to short covering, while others see it as a temporary bounce.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention amid a sharp, sector-wide selloff in AI infrastructure and neocloud stocks, as traders debate whether the AI buildouts debt, funding needs and uncertain profitability justify lower valuations. Bulls call the decline an oversold, market-driven pullback and are buying dips, while bears warn that financing risks and bubble concerns could drive further losses; the latest bounce has not settled the debate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The move appears tied to Tempus AIs Q3 earnings beat, with revenue of $411.5 million versus roughly $409 million expected, and higher full-year 2026 revenue guidance of $1.60 billion$1.605 billion.

TEM Q3 Earnings Call Highlights Growth and 2027 Pricing Upside

Tempus AI raises its 2026 revenue outlook as oncology demand, expanding data partnerships and reimbursement-driven pricing gains fuel growth prospects for 2027.

3 Stocks to Watch Following Guidance Upgrades

The Q3 earnings cycle continues to roll along, with several healthcare companies delivering positive results and raising their outlooks as a result.

Noteworthy Monday Option Activity: TEM, RIVN, NRG

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Tempus AI Inc (Symbol: TEM), where a total of 53,942 contracts have traded so far, representing approximately 5.4 million underlying shares. That amounts to about 83.8...

Tempus (TEM) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Tempus (TEM) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Tempus AI (TEM) Beats Q3 Earnings and Revenue Estimates

Tempus (TEM) delivered earnings and revenue surprises of +177.78% and +0.05%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings

Equity

The company also cleared regulatory review of its pending acquisition of Personalis (PSNL), with a shareholder vote scheduled for November 30.

Tempus Reports Third Quarter 2026 Results

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today reported financial results for the quarter ended September 30, 2026. Q3 was another record quarter, as we delivered $411.5 million of revenue, led by accelerating unit growth of 32...

Tempus AI Earnings Ahead: Is TEM Set Up To Pop or Drop?

Tempus AI, a company that Cathie Wood has invested in, will publish its financial results this week as its volatility continues.read more...

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3

Ark Invest increased its exposure to several widely followed biotechnology stocks during the session.

TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?

Tempus AI or Doximity: Which medical information systems stock offers better value? Compare growth prospects, AI expansion, earnings estimates and valuation.

This account has been verified as an official TEM representative.

Verified Account

Tempus AI

$TEM Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.07 up 163.64% YoY
• Reported revenue of $411.54M up 23.14% YoY

Stocktwits

Tempus AI Inc

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.07 up 163.64% YoY
• Reported revenue of $411.54M up 23.14% YoY

This account has been verified as an official STOCKTWITS representative.

Stocktwits Earnings

• Reported GAAP EPS of $0.07 up 163.64% YoY
• Reported revenue of $411.54M up 23.14% YoY

Tempus AI expects operating losses and expenses to increase, received payment on approximately 55% of clinical oncology and 50% of hereditary tests, and disclosed Personalis closing and integration risks.

Tempus AI grew Diagnostics revenue and testing volume, expanded Data and applications through Insights, Next and new-customer adoption, and signed a BMS SOW with $137.5M in fixed payments.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Bullish Sentiment

<ul class="summary-bullets"><li>Tempus raised the lower end of its full-year revenue guidance to $1.60 billion from $1.595 billion.</li><li>The company’s data licensing bookings exceeded $550 million year to date following its October collaboration with Bristol Myers Squibb.</li><li>Cathie Wood's ARK Invest purchased 154,521 Tempus shares through two ETFs, ahead of earnings.</li></ul><p>Tempus AI Inc. (TEM) shares rose in Monday's premarket trading after the company reported record third-quarter revenue and raised its 2026 outlook.&nbsp;</p><p>CEO Eric Lefkofsky called it “another record quarter,” citing accelerating oncology testing volumes and growth in its Data and Applications business.</p><p>The healthcare technology firm’s revenue rose 23% year over year to $411.5 million, surpassing estimates of approximately $409.4 million, according to FiscalAI data.&nbsp;</p><p>Tempus AI’s adjusted earnings before interest, taxes, depreciation and amortization&nbsp;(EBITDA) increased to $25.6 million from $1.5 million a year earlier, while net loss narrowed to $14.9 million from $80 million.</p><p>At the time of this writing, <a href="https://stocktwits.com/symbol/TEM">TEM stock</a> traded more than 4% higher in premarket.</p><h2 class="st-heading-2">Oncology Growth Drives Record Revenue</h2><p>Tempus' Diagnostics revenue grew 20% year over year to $303.5 million, supported by 32% growth in oncology testing volumes, while Minimal residual disease (MRD) testing volumes surged 300% to approximately 12,000 tests.</p><p>Data and Applications revenue increased 33% to $108.1 million, with its Insights business growing 29%. The company also reported a 27% increase in gross profit to $266.7 million, led by growth in Data and Applications.</p><p>CEO Eric Lefkofsky said, “These results reinforce the durability of our model as our best-in-class diagnostic platform enhances our data and AI offerings, distinguishes our business from our many competitors, and helps drive our performance quarter after quarter.”</p><h2 class="st-heading-2">Tempus Raises 2026 Revenue Outlook</h2><p>Tempus raised the lower end of its full-year revenue guidance to $1.60 billion from $1.595 billion, keeping the upper end unchanged at $1.605 billion. The outlook implies approximately 25% annual revenue growth.</p><p>The company maintained its full-year adjusted EBITDA forecast of approximately $65 million.</p><p>Tempus also said its data licensing bookings exceeded $550 million year to date following its October collaboration with Bristol Myers Squibb (BMY). The company also cleared regulatory review of its pending acquisition of Personalis (<a href="https://stocktwits.com/symbol/PSNL">PSNL</a>), with a shareholder vote scheduled for November 30.</p><h2 class="st-heading-2">Cathie Wood's ARK Buys Tempus Ahead Of Earnings</h2><p>Cathie Wood's ARK Invest purchased 154,521 Tempus shares last week on Friday, just ahead of the company's third-quarter earnings release.</p><p>The purchases included 93,407 shares through the ARK Innovation ETF (<a href="https://stocktwits.com/symbol/ARKK">ARKK</a>) and 61,114 shares through the ARK Genomic Revolution ETF (<a href="https://stocktwits.com/symbol/ARKG">ARKG</a>). The buying followed two sessions of selling, during which ARKK reduced its Tempus holdings by a combined 65,996 shares.</p><h2 class="st-heading-2">What Retail Thinks About TEM Stock</h2><p>On Stocktwits, retail investor sentiment around Tempus AI (TEM) stock remained ‘bearish’</p><figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_11_02_180641_ed5f8f3553.png" alt="Screenshot 2026-11-02 180641.png" width="801" height="421"><figcaption>TEM stock retail sentiment on November 2, as of 08:00 a.m. ET | Source: Stocktwits</figcaption></figure><p>So far in 2026, TEM stock has risen nearly 16%. By comparison, the iShares Future AI &amp; Tech ETF (ARTY), which holds the stock, has risen around 38% over the same period.</p><p>See Also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/chkp-stock-tanks-as-q3-revenue-misses-estimates-ceo-says-recovery-is-taking-longer-than-anticipated/cNG9DdBR9PR">CHKP Stock Tanks As Q3 Revenue Misses Estimates — CEO Says Recovery Is ‘Taking Longer Than Anticipated’</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration logo of Tempus AI is seen on a smartphone against a screen displaying a trade markets illustration on April 15, 2024 in Krakow, Poland. (Photo by Dominika Zarzycka/NurPhoto via Getty Images)

Tempus raised the lower end of its full-year revenue guidance to $1.60 billion from $1.595 billion.The company’s data licensing bookings exceeded $550 million year to date following its October collaboration with Bristol Myers Squibb.Cathie Wood's ARK Inv

ARK Investment Management LLC - ARK Genomic Revolution ETF

ARK Innovation ETF

iShares Future AI & Tech ETF

Personalis Inc

Get real-time Tempus AI Inc (TEM) stock price, news, financials, community insights, and trading ideas.

Feed

News

Sentiment

Earnings

Fundamentals

Info

TEM News